Generic Drug Analysis & Statistics, January 2015 (p2)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

31-60 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Silodosin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Silodosin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Telmisartan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Telmisartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Vardenafil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vardenafil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Hydrochlorothiazide, Losartan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Hydrochlorothiazide, Losartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Lercanidipine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Lercanidipine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
International Directory of Generics Companies 2015

International Directory of Generics Companies 2015

  • $ 275
  • Industry report
  • January 2015
  • by Asia Pacific Infoserv

The most comprehensive and accurate Directory of companies and executives in the generics industry Internationally

  • Industries : Generic Drug
Abbott Laboratories - Strategy and SWOT Report

Abbott Laboratories - Strategy and SWOT Report

  • $ 175
  • Company report
  • December 2014
  • by MarketLine

Abbott Laboratories - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Generic Drug
  • Countries : United States, Netherlands, Canada, Spain, Italy, France, Germany, Japan
PharmaZell GmbH SWOT Analysis, Strategy, Revenues and Profits

PharmaZell GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2015
  • by Global Data

PharmaZell GmbH (PharmaZell) is an established private company, engaged in the development, manufacturing and providing of active pharmaceutical ingredients (APIs) and intermediates. The company serves ...

  • Industries : Generic Drug
Generics in the United States, MarketLine

Generics in the United States, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile ...

  • Industries : Generic Drug
  • Countries : United States
Global Generics, MarketLine

Global Generics, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : World
Generics in Belgium, MarketLine

Generics in Belgium, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : Belgium
Generics in Canada, MarketLine

Generics in Canada, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : Canada
Generics in China, MarketLine

Generics in China, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : China
Generics in Germany, MarketLine

Generics in Germany, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : Germany
Generics in Asia-Pacific, MarketLine

Generics in Asia-Pacific, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also ...

  • Industries : Generic Drug
  • Countries : China
Generics in Italy, MarketLine

Generics in Italy, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : Italy
Generics in Japan, MarketLine

Generics in Japan, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : Japan
Generics in Europe, MarketLine

Generics in Europe, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : Europe
Generics in the Netherlands, MarketLine

Generics in the Netherlands, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also ...

  • Industries : Generic Drug
  • Countries : Netherlands
Generics in France, MarketLine

Generics in France, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : France
Generics in Spain, MarketLine

Generics in Spain, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains ...

  • Industries : Generic Drug
  • Countries : Spain
Generics in the United Kingdom, MarketLine

Generics in the United Kingdom, MarketLine

  • $ 350
  • Industry report
  • December 2014
  • by MarketLine

Introduction Generics in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile ...

  • Industries : Generic Drug
  • Countries : United Kingdom
Brazil Pharmaceutical Market Outlook 2018

Brazil Pharmaceutical Market Outlook 2018

  • $ 1 000
  • Industry report
  • December 2014
  • by RNCOS

Brazil is considered as one of the most lucrative healthcare markets, accounting for the highest healthcare expenditure in Latin America. It is the largest pharmaceutical market in Latin America and the ...

  • Industries : Generic Drug
  • Countries : Brazil
Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Generic Drug
  • Countries : Germany
Ascent Pharmahealth Limited (Symbol:APH) SWOT Analysis, Strategy, Revenues and Profits

Ascent Pharmahealth Limited (Symbol:APH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Generic Drug
  • Countries : Australia
Pharmascience Inc. SWOT Analysis, Strategy, Revenues and Profits

Pharmascience Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Generic Drug
  • Countries : Canada
Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Generic Drug
  • Countries : Germany, Argentina, Brazil, Canada, Slovenia, Poland, Austria, India
Zentiva NV (Symbol:BAAZEN) SWOT Analysis, Strategy, Revenues and Profits

Zentiva NV (Symbol:BAAZEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Generic Drug
  • Countries : Netherlands, Europe, Czech Republic
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Out-of-pocket spending will continue to be the main driver behind the growth of Bulgaria’s pharmaceutical industry, though this feature also makes the industry highly vulnerable to the wide ...

  • Industries : Generic Drug
  • Countries : Bulgaria
Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

Summary Navamedic ASA (Navamedic) is a pharmaceutical products company. It undertakes the in-licensing and sale of generics and specialty pharmaceuticals, medical devices, food supplements and other products ...

  • Industries : Generic Drug

7 Companies

Read our Company Profiles

Mylan Inc.

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Teva Pharmaceuticals

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.